Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Cofrogliptin

Copy Product Info
😃Good
Catalog No. T62985Cas No. 1844874-26-5
Alias HSK-7653, HSK7653, HSK 7653

Cofrogliptin (HSK7653) is an orally available dipeptidyl peptidase-4 (DPP-4) inhibitor with hypoglycemic effects, which can be used to study type 2 diabetes (T2D).

Cofrogliptin

Cofrogliptin

Copy Product Info
😃Good
Purity: 99.25%
Catalog No. T62985Alias HSK-7653, HSK7653, HSK 7653Cas No. 1844874-26-5
Cofrogliptin (HSK7653) is an orally available dipeptidyl peptidase-4 (DPP-4) inhibitor with hypoglycemic effects, which can be used to study type 2 diabetes (T2D).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$71-In Stock
5 mg$172-In Stock
10 mg$277-In Stock
25 mg$556-In Stock
50 mg$893-In Stock
1 mL x 10 mM (in DMSO)$176-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.25%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Cofrogliptin (HSK7653) is an orally available dipeptidyl peptidase-4 (DPP-4) inhibitor with hypoglycemic effects, which can be used to study type 2 diabetes (T2D).
Targets&IC50
DPP4:4.2 nM
In vitro
Evaluate the DPP-4 inhibitory activities of Cofrogliptin, Cofrogliptin exhibited a much better in vitro activity, which significantly enhanced the potency IC50 = 4.2 nM. [1]
In vivo
In vehicle group, mice were intragastrically given 1% hypromellose at a volume of 20 mL/kg. In treatment groups, mice were intragastrically administrated either omarigliptin at 30 mg/kg or varying doses of Cofrogliptin. Cofrogliptin inhibitory activity on plasma DPP-4 was assayed ex vivo in ob/ob mice. After a single dose, Cofrogliptin exhibited a much stronger inhibition capability of plasma DPP-4 than omarigliptin in a dose dependent manner.
Monkeys were intragastrically administrated either vehicle or Cofrogliptin (10 mg/kg) at a volume of 5 mL/kg. The ex vivo plasma DPP-4 inhibition was also assayed for Cofrogliptin in rhesus monkeys. After a single dose of 10 mg/kg, Cofrogliptin possessed the capability of plasma DPP-4 inhibition over 80% for at least 12 days. [1]
SynonymsHSK-7653, HSK7653, HSK 7653
Chemical Properties
Molecular Weight466.43
FormulaC18H19F5N4O3S
Cas No.1844874-26-5
SmilesC(F)(F)(F)[C@@H]1[C@@H](C[C@H](N)[C@H](O1)C2=C(F)C=CC(F)=C2)N3CC=4C(C3)=NN(S(C)(=O)=O)C4
Storage & Solubility Information
Storagestore at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (171.52 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1439 mL10.7197 mL21.4394 mL107.1972 mL
5 mM0.4288 mL2.1439 mL4.2879 mL21.4394 mL
10 mM0.2144 mL1.0720 mL2.1439 mL10.7197 mL
20 mM0.1072 mL0.5360 mL1.0720 mL5.3599 mL
50 mM0.0429 mL0.2144 mL0.4288 mL2.1439 mL
100 mM0.0214 mL0.1072 mL0.2144 mL1.0720 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Cofrogliptin | purchase Cofrogliptin | Cofrogliptin cost | order Cofrogliptin | Cofrogliptin chemical structure | Cofrogliptin in vivo | Cofrogliptin in vitro | Cofrogliptin formula | Cofrogliptin molecular weight